Author:
Núñez-Gómez Laura,Mesonero-Gismero Francisco,Albillos-Martínez Agustín,López-Sanromán Antonio
Subject
Gastroenterology,Hepatology
Reference51 articles.
1. Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor;Kaymakcalan;Clin Immunol,2009
2. Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: Meta-analysis of placebo-controlled trials;Peyrin-Biroulet;Clin Gastroenterol Hepatol,2008
3. Inflammatory bowel disease as a paradoxical effect of anti-TNF alpha therapy;Iriarte;Gastroenterol Hepatol.,2017
4. U.S. Food & Drug Administration. 2018. Disponible en: https://www.fda.gov/Drugs/default.htm
5. European Medicines Agency. 2018. Disponible en: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/landing/epar_search.jsp&mid=WC0b01ac058001d124
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献